Research output per year
Research output per year
Research output
Search results
-
2021
Influence of drug safety advisories on drug utilization: An international interrupted time series and meta-analysis study
Morrow, R. L., Mintzes, B., Souverein, P. C., Bruin, M. L. D., Roughead, E. E., Lexchin, J., Kemp-Casey, A., Puil, L., Sketris, I., Mangin, D., CE, H., Pearson, S.-A., Lopert, R., Bero, L., Ofori-Asenso, R., Gnjidic, D., Sarpatwari, A. & Dormuth, C. R., Aug 2021.Research output: Contribution to conference › Abstract › Academic
-
2019
Impact of European Benefit-Risk reassessment procedures on drug prescribing practices in Denmark
Bruin, M. L. D., CE, H. & Andersen, M., Aug 2019.Research output: Contribution to conference › Abstract › Academic
-
MEDICINES AUTHORITY REGULATOR AND INDUSTRY PERCEPTIONS OF BIOSIMILAR INTERCHANGEABILITY
Druedahl, L. C., Bruin, M. L. D., Hoogland, H., Minssen, T., van de Weert, M., Sporrong, S. K. & Almarsdottir, A. B., Dec 2019.Research output: Contribution to conference › Abstract › Academic
-
2018
Impact of the 2012 pharmacovigilance legislation on the harmonisation of DHPCS in the EU
Olafsdottir, G., Bukhave, S. M., Kalligeros, G., CE, H. & Bruin, M. L. D., Aug 2018.Research output: Contribution to conference › Abstract › Academic
-
What is real-world data? A review of definitions based on literature and stakeholder interviews
Makady, A., De Boer, A., Hillege, H., Klungel, O. & Goettsch, W., 1 Aug 2018, p. 410. 1 p.Research output: Contribution to conference › Abstract › Academic
-
2017
How to Measure the Impact of Pharmacovigilance Activities on Public Health?
Gardarsdottir, H., Kant, A., Bruin, M. L. D., CE, H., Pan, G. D. & Way, D., Aug 2017.Research output: Contribution to conference › Abstract › Academic
-
Practical Points to Address Uncertainties in Risk Management Planning
Shakir, S., Bloem, L., Bruin, M. L. D., Hoekman, J., Leufkens, H. & Ryan, P., Aug 2017.Research output: Contribution to conference › Abstract › Other research output